Clinical Trials in Ohio

Showing 8481-8500 of 15,929 trials

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

NCT00941486

The objective of this study is to evaluate the efficacy of FST-100 (PVP-I 0.4% and dexamethasone 0.1%) Ophthalmic Suspension in the treatment of suspected acute adenoviral conjunctivitis.

Acute Adenoviral Conjunctivitis

Shire30 participantsStarted Jun 2009

Torrance, California, United States • Colorado Springs, Colorado, United States • Hamden, Connecticut, United States +10 more locations

COMPLETEDNA32 miles

Mechanisms and Management of Infant Dysphagia

NCT02583360

The purpose of the investigator's study is to evaluate the causes of feeding difficulty in infants. New treatments can be possible only if the cause is known. In this study, the investigator plans to evaluate the movement of the muscles in an infant's mouth, throat (pharynx) and food pipe (esophagus) that are responsible for moving the food down into the stomach and that help protect an infants airway.

DysphagiaAirway AspirationAirway Penetration

Sudarshan Jadcherla109 participantsStarted Oct 2015

Columbus, Ohio, United States

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

Mechanisms and Management of Infant Dysphagia

Find Trials by Condition in Ohio

St.Jude Medical Cardiac Lead Assessment Study

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Study of Octanorm Subcutaneous IG in Patients With PID

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs

Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma